Literature DB >> 18254778

Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast.

Sergio Fernandez-Aguilar1, Jean-Christophe Noël.   

Abstract

Tubular carcinoma (TC) is a distinctive type of grade I (G1) ductal carcinoma with particularly favourable outcome and low rate of axillary metastases. To the best of our knowledge, few data are available in the literature concerning the expression of molecules mediating intercellular and cell-matrix interactions in TC. We examined with immunohistochemical methods the expression of galectin 3 and cathepsin D in 17 TC and in 33, 31 and 28 ductal carcinomas of G1, grade II (G2) and grade III (G3), respectively. Results were compared using Chi-square test. Galectin 3 expression was higher in TC than in G1 carcinomas (p<0.05). The pattern of immunostaining was also different with a focal cytoplasmic apical reinforcement in TC. However, cathepsin D stromal and epithelial expression was similar in TC and G1 cases (p>0.05), and lower than in G2 and G3 patients at a stromal level. The higher expression of galectin 3 in TC and its focal staining (apical) pattern suggests that within the group of G1 carcinomas, galectin 3 expression varies according to histological type, and may correlate with prognosis and metastatic potential. We also suggest that cathepsin D could not be involved in neoplastic progression and metastasis in low-grade (G1) ductal breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18254778     DOI: 10.1111/j.1600-0463.2008.00753.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  4 in total

1.  The Expression of Galectin-3 in Tumor and Cancer-Associated Fibroblasts in Invasive Micropapillary Breast Carcinomas: Relationship with Clinicopathologic Parameters.

Authors:  Yasemin Çakır; Canan Kelten Talu; Özlem Mermut; Didem Can Trabulus; Esra Arslan
Journal:  Eur J Breast Health       Date:  2021-10-04

2.  Galectins as cancer biomarkers.

Authors:  Vitaly Balan; Pratima Nangia-Makker; Avraham Raz
Journal:  Cancers (Basel)       Date:  2010-04-20       Impact factor: 6.639

3.  Tubular carcinoma of the breast: clinicopathologic features and survival outcome compared with ductal carcinoma in situ.

Authors:  Yejin Min; Soo Youn Bae; Hyun-Chul Lee; Jun Ho Lee; Minkuk Kim; Jiyoung Kim; Se Kyung Lee; Won Ho Kil; Seok Won Kim; Jeong Eon Lee; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

4.  Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.

Authors:  Andrée-Anne Grosset; Françoise Poirier; Louis Gaboury; Yves St-Pierre
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.